Activation and blockade of dorsal hippocampal Serotonin6 receptors regulate anxiety-like behaviors in a unilateral 6-hydroxydopamine rat model of Parkinson's disease. (2nd September 2019)
- Record Type:
- Journal Article
- Title:
- Activation and blockade of dorsal hippocampal Serotonin6 receptors regulate anxiety-like behaviors in a unilateral 6-hydroxydopamine rat model of Parkinson's disease. (2nd September 2019)
- Main Title:
- Activation and blockade of dorsal hippocampal Serotonin6 receptors regulate anxiety-like behaviors in a unilateral 6-hydroxydopamine rat model of Parkinson's disease
- Authors:
- Liu, Kun Cheng
Guo, Yuan
Zhang, Jin
Chen, Li
Liu, Yi Wei
Lv, Shu Xuan
Xie, Wen
Wang, Hui Sheng
Zhang, Yu Ming
Zhang, Li - Abstract:
- ABSTRACT: Objectives : This study aimed to investigate the effect of serotonin6 (5-HT6 ) receptors in the dorsal hippocampus (dHip) on the regulation of Parkinson's disease (PD)-associated anxiety. Methods : We examined whether intra-dHip injection of both 5-HT6 receptor agonist and antagonist was involved in the regulation of anxiety-like behaviors in sham-operated rats and rats with unilateral 6-hydroxydopamine (6-OHDA) lesions of the medial forebrain bundle by the open-field and elevated plus maze (EPM) tests. Four weeks after injection of 6-OHDA, the concentrations of dopamine (DA), noradrenaline (NA) and 5-hydroxytryptamine (5-HT) in relative related brain regions were measured by reverse-phase high-performance liquid chromatography. Results : In sham-operated rats, intra-dHip injection of both 5-HT6 receptor agonist WAY208466 (3 and 6 µg/rat) and antagonist SB258585 (4 µg/rat) increased the percentage of time spent in the center area in the open-field test and percentages of open arm entries and open arm time in EPM test, indicating that induced anxiolytic effects. In the lesioned rats, WAY208466 (1.5, 3 and 6 µg/rat) produced anxiolytic responses, whereas SB258585 (2 and 4 µg/rat) produced anxiogenic effects. Neurochemical results showed that intra-dHip injection of WAY208466 (6 µg/rat) decreased NA level in the amygdala, and SB258585 (4 µg/rat) increased DA levels in the dHip and vHip in sham-operated rats, whereas WAY208466 increased DA levels in the dHip, vHip, andABSTRACT: Objectives : This study aimed to investigate the effect of serotonin6 (5-HT6 ) receptors in the dorsal hippocampus (dHip) on the regulation of Parkinson's disease (PD)-associated anxiety. Methods : We examined whether intra-dHip injection of both 5-HT6 receptor agonist and antagonist was involved in the regulation of anxiety-like behaviors in sham-operated rats and rats with unilateral 6-hydroxydopamine (6-OHDA) lesions of the medial forebrain bundle by the open-field and elevated plus maze (EPM) tests. Four weeks after injection of 6-OHDA, the concentrations of dopamine (DA), noradrenaline (NA) and 5-hydroxytryptamine (5-HT) in relative related brain regions were measured by reverse-phase high-performance liquid chromatography. Results : In sham-operated rats, intra-dHip injection of both 5-HT6 receptor agonist WAY208466 (3 and 6 µg/rat) and antagonist SB258585 (4 µg/rat) increased the percentage of time spent in the center area in the open-field test and percentages of open arm entries and open arm time in EPM test, indicating that induced anxiolytic effects. In the lesioned rats, WAY208466 (1.5, 3 and 6 µg/rat) produced anxiolytic responses, whereas SB258585 (2 and 4 µg/rat) produced anxiogenic effects. Neurochemical results showed that intra-dHip injection of WAY208466 (6 µg/rat) decreased NA level in the amygdala, and SB258585 (4 µg/rat) increased DA levels in the dHip and vHip in sham-operated rats, whereas WAY208466 increased DA levels in the dHip, vHip, and amygdala in the lesioned rats. Discussion : dHip 5-HT6 receptors are involved in the regulation of anxiety-like behaviors, which may be mediated through different neurochemical mechanisms, and the dHip is an important site involved in these effects. Abbreviation : PD: Parkinson's disease;6-OHDA: 6-hydroxydopamine; dHip: dorsal hippocampus; vHip: ventral hippocampus; 5-HT: serotonin; MFB: medial forebrain bundle; DA: dopamine; NA: noradrenaline; EPM: elevated plus-maze; GABA: gamma-aminobutyric acid; BLA: basolateral amygdala … (more)
- Is Part Of:
- Neurological research. Volume 41:Number 9(2019)
- Journal:
- Neurological research
- Issue:
- Volume 41:Number 9(2019)
- Issue Display:
- Volume 41, Issue 9 (2019)
- Year:
- 2019
- Volume:
- 41
- Issue:
- 9
- Issue Sort Value:
- 2019-0041-0009-0000
- Page Start:
- 791
- Page End:
- 801
- Publication Date:
- 2019-09-02
- Subjects:
- Parkinson's disease -- anxiety -- dorsal hippocampus -- 5-HT6 receptors
Neurology -- Periodicals
Neurosciences -- Periodicals
616.8005 - Journal URLs:
- http://catalog.hathitrust.org/api/volumes/oclc/3983345.html ↗
http://www.ingentaconnect.com/content/maney/nres ↗
http://www.maney.co.uk/search?fwaction=show&fwid=503 ↗
http://www.tandfonline.com/toc/yner20/current ↗
http://maneypublishing.com/ ↗ - DOI:
- 10.1080/01616412.2019.1611204 ↗
- Languages:
- English
- ISSNs:
- 0161-6412
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 11409.xml